Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 232,729,845 papers from all fields of science
Search
Sign In
Create Free Account
Allopurinol:MCnc:Pt:Ser/Plas:Qn
Known as:
Allopurinol:MKnz:Pkt:Ser/Plas:Qn
, Allopurinol:Concentration de masse:Temps ponctuel:Sérum/Plasma:Quantitatif
, alopurinol:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Allopurinol
Plas
Serum
Unit of Mass Concentration
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
[De-sensitization to allopurinol in a patient with tophi gout].
E. López-Rocha
,
Gerardo Hernández-Montoya
,
Alberto Hernán Rodríguez-Pesina
,
Karen Alicia Rodríguez-Mireles
Revista Alergia México
2018
Corpus ID: 117222336
BACKGROUND Allopurinol is a xanthine oxidase inhibitor used in the treatment of patients with gout. Approximately 2% of patients…
Expand
2017
2017
Características demográficas, clínicas e terapêutica de pacientes com diagnóstico de gota atendidos no ambulatório de reumatologia da Fundação Santa Casa de Misericórdia do Pará
João Frazão
2017
Corpus ID: 201989159
Gota e uma artropatia causada pela deposicao de cristais de monourato de sodio em articulacoes, como resultado da hiperuricemia…
Expand
Review
2017
Review
2017
AKTIVITAS ANTIHIPERURISEMIA BEBERAPA TANAMAN DI ASIA
Safira Annissa
,
Sri Adi Sumiwi
2017
Corpus ID: 80290336
Hiperurisemia adalah suatu keadaan yang ditandai dengan meningkatnya kadar asam urat karena disfungsi dalam produksi atau…
Expand
2012
2012
PENGARUH TWEEN 80 DALAM DISPERSI PADAT ALOPURINOL - PVP K30 TERHADAP LAJU DISOLUSI ALOPURINOL
Novinta Olivia Christ Tindar
2012
Corpus ID: 105100588
The aim of the present study was to improve the dissolution rate of a poorly water-soluble drug allopurinol (ALP) by…
Expand
2011
2011
Estudio farmacoepidemiológico de potenciales interacciones farmacológicas y sus determinantes, en pacientes hospitalizados
D. Mino-León
,
Ma. Eugenia Galván-Plata
,
S. V. Doubova
,
S. Flores-Hernández
,
H. Reyes-Morales
2011
Corpus ID: 67955632
Antecedentes: Prescribir conjuntamente varios medicamentos favorece la presencia de interacciones farmaco-farmaco (IF-F), fracaso…
Expand
2011
2011
KARAKTERISTIK DISPERSI PADAT ALOPURINOL-NIKOTINAMID
Ardiana Putri Kusumaningtyas
2011
Corpus ID: 139827944
Allopurinol is a commonly used drug in the treatment of chronic gout or hyperuricemia. One of the major problems with also is…
Expand
Review
2010
Review
2010
Geographical distribution, clinical presentation, treatment and prevention of canine leishmaniosis in Portugal: a 2007 field survey Resultados de um inquérito realizado em 2007 sobre a distribuição…
A. Oliveira
,
Suraya Diaz
,
C. Santos
,
Patrick Bourdeau
,
I. Fonseca
,
Ciências Veterinárias
2010
Corpus ID: 54805490
21 Resumo: A leishmaniose canina, doença endémica em Portugal, é causada por Leishmania infantum, sendo transmitida por…
Expand
2008
2008
Síndrome de hipersensibilidad retardada a alopurinol
E. R. Gamón
,
José Luis González Carazo
,
C. L. Argente
,
V. Z. Ninet
,
V. Miquel
2008
Corpus ID: 72074626
2006
2006
PERBANDINGAN BIOAVAILABILITAS ALOPURINOL DALAM SEDIAAN GENERIK DAN PATEN SECARA IN VITRO
D. Nugraheni
2006
Corpus ID: 68862403
COMPARATIVE IN VITRO BIOAVAILABILITY OF ALLOPURINOL IN GENERIC AND ITS PATENT PRODUCT Dina Nugraheni1, Henna Rya Sunoko2…
Expand
2001
2001
Modelo experimental de reimplante de membro após isquemia quente em ratos e efeito da estreptoquinase, alopurinol e terapia com oxigênio hiperbárico
J. A. D. Silva
,
D. Simão
,
+4 authors
Marcus Castro Ferreira
La Revue de medecine
2001
Corpus ID: 176650383
A isquemia prolongada leva a alterações na microcirculação tecidual e liberação de radicais livres do oxigênio conhecidos como…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE